News
MNOV
1.450
-1.36%
-0.020
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Lixte Biotechnology (NASDAQ:LIXT) shares moved upwards by 67.2% to $3.77 during Wednesday's pre-market session. The company's, Q4 earnings came out today. NovoCure stock rose 17.9% and Nutriband shares rose 24.34% in the same session. Akili stock decreased by 20.6% and OpGen stock fell 15.67% during the session.
Benzinga · 1d ago
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
Shares of MariaDB plc rose sharply in today's pre-market trading. Progress Software announced it is possibly considering an offer for the company. Destiny Tech100 Inc. Shares rose 52.9% to $13.76 in pre- market trading. PaySign, Inc. And Trump Media & Technology Group Corp. Were among the stocks moving in Tuesday's trading.
Benzinga · 1d ago
Reported Earlier, MediciNova Receives Notice Of Allowance From Japan Patent Office For MN-166 In Macular Injury Treatment
Benzinga · 1d ago
MediciNova Gets Patent in Japan for Multiple Sclerosis-Related Treatment
MediciNova says it has received a Japanese patent allowance for its treatment for macular injury linked to multiple sclerosis. The patent covers MN-166, a small-molecule compound. The company expects the patent allowance to increase the potential value of the compound.
Dow Jones · 1d ago
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
MediciNova, Inc. Received a Notice of Allowance from the Japan Patent Office for a pending patent application. The application covers the treatment of macular injury associated with progressive multiple sclerosis. The company is a biopharmaceutical company traded on the NASDAQ Global Market.
Barchart · 2d ago
Weekly Report: what happened at MNOV last week (0318-0322)?
Weekly Report · 3d ago
Reported Earlier, MediciNova Announces Two Abstracts Regarding MN-001 And MN-002 Accepted For Presentation At The 92nd EAS 2024 Congress
MediciNova, Inc. Is a biopharmaceutical company traded on the NASDAQ Global Market and the Tokyo Stock Exchange. Two abstracts have been accepted for poster presentation at the European Atherosclerosis Society 2024 Congress in May 2024. The abstracts will discuss MN-001's safety and effectiveness in patients with liver disease.
Benzinga · 03/21 07:14
MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society
MediciNova, Inc. Is a biopharmaceutical company traded on the NASDAQ Global Market and the Tokyo Stock Exchange. Two abstracts will be accepted for poster presentation at the European Atherosclerosis Society's 2024 Congress in May 2024. The abstracts examine the safety and effectiveness of MN-001.
Barchart · 03/20 18:00
Weekly Report: what happened at MNOV last week (0311-0315)?
Weekly Report · 03/18 10:37
Weekly Report: what happened at MNOV last week (0304-0308)?
Weekly Report · 03/11 10:34
Weekly Report: what happened at MNOV last week (0226-0301)?
Weekly Report · 03/04 10:37
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Janux Therapeutics stock rose 120.5% to $33.3 during Tuesday's pre-market session. The company's, Q4 earnings came out yesterday. Viking Therapeutic shares increased by 97.24% and TransMedics Gr stock rose 22.2%. NRX Pharmaceuticals shares decreased by 22.9% during the day.
Benzinga · 02/27 13:06
Weekly Report: what happened at MNOV last week (0219-0223)?
Weekly Report · 02/26 10:46
Weekly Report: what happened at MNOV last week (0212-0216)?
Weekly Report · 02/19 10:47
12 Health Care Stocks Moving In Friday's Pre-Market Session
China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 25.2% to $2.73 during Friday's pre-market session. Sarepta Therapeutics shares moved upwards by 14.5%. MediciNova stock rose by 17.77% as the company's Q4 earnings report came out yesterday. Losers Inventiva and T2 Biosystems also lost ground.
Benzinga · 02/16 13:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
KalVista Pharma (NASDAQ:KALV) stock moved upwards by 31.5% to $21.1 during Tuesday's pre-market session. Biodexa Pharmaceuticals stock rose 21.37% and Jin Medical International stock rose 25.75% in the same session. Losers Sientra ( NASDAQ:SIEN) and G1 Therapeutics fell by 51.3% and 11.17% respectively.
Benzinga · 02/13 13:06
Weekly Report: what happened at MNOV last week (0205-0209)?
Weekly Report · 02/12 10:39
Weekly Report: what happened at MNOV last week (0129-0202)?
Weekly Report · 02/05 10:46
Weekly Report: what happened at MNOV last week (0122-0126)?
Weekly Report · 01/29 10:38
Weekly Report: what happened at MNOV last week (0115-0119)?
Weekly Report · 01/22 10:41
More
Webull provides a variety of real-time MNOV stock news. You can receive the latest news about Medicinova through multiple platforms. This information may help you make smarter investment decisions.
About MNOV
MediciNova, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States market. It is focused on its development activities on MN-166 (ibudilast) for neurological and other disorders, such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction (e.g., methamphetamine dependence, opioid dependence, and alcohol dependence), prevention of acute respiratory distress syndrome (ARDS), and Long COVID, and MN-001 (tipelukast) for fibrotic and other diseases, such as nonalcoholic fatty liver disease (NAFLD) and idiopathic pulmonary fibrosis (IPF). The Company's pipeline also includes MN-221 (bedoradrine) for the treatment of acute exacerbation of asthma and MN-029 (denibulin) for solid tumor cancers.